MARLBOROUGH, Mass., March 16 (UPI) -- U.S. medical device firm Cytyc Corp. said Friday it has completed its acquisition of privately held women's health company Adiana.
Cytyc said its newly acquired firm has developed an investigational non-surgical alternative to tubal ligation for permanent contraception for women.
The companies did not disclose financial terms of the deal, which closed Friday.
"We believe the acquisition of Adiana provides another terrific growth opportunity and we are very excited to expand our surgical product offerings into reproductive health," said John McDonough, president of Cytyc Development Company.
"We believe this acquisition is an excellent strategic fit for Cytyc as it complements our NovaSure Endometrial Ablation System and it allows us to leverage our formidable worldwide sales force, which is focused on delivering clinical solutions to the OB/GYN community."
